Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Hairy Cell Leukemia

Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line

Leukemia volume 14, pages 696–705 (2000)Cite this article

Abstract

The expression of nitric oxide synthase (NOS) isoforms was investigated in the established ESKOL hairy cell line and in leukemic cells of patients with hairy cell leukemia (HCL). By reverse transcription-polymerase chain reaction (RT-PCR), these cells were found to spontaneously express inducible NOS (iNOS)-specific mRNA, but not endothelial constitutive NOS (ecNOS) mRNA. The iNOS protein was detected by immunofluorescence in the cytoplasm of permeabilized leukemic cells and ESKOL cells, using different anti-iNOS monoclonal antibodies. A protein of 135 kDa was identified by Western blotting in ESKOL and HCL lysates, confirming the presence of an iNOS in these cells. Cytosolic homogenates displayed NOS catalytic activity, as measured by the conversion of 14C-labelled L-arginine into 14C L-citrulline and by detection in situ using the DAF-2DA (diaminofluorescein diacetate) NO-sensitive fluorescent probe. Ligation of CD23 (low affinity IgE receptor) was found to increase iNOS expression in ESKOL and conversely to decrease the percentage of cells undergoing apoptosis, as measured by the percentage of cells expressing annexin V. These results indicate that, as in chronic B cell lymphocytic leukemia cells (B-CLL) a functional iNOS is expressed constitutively in hairy cells that contributes to protecting these tumoral cells from apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  1. Hsu SM, Yang K, Jaffe ES . Hairy cell leukemia: a B cell neoplasm with unique antigen phenotype Am Clin Pathol 1983 80: 421–428

    Article  CAS  Google Scholar 

  2. Jansen J, Lebien T, Kersey JH . The phenotype of the neoplastic cells of the hairy cell leukemia studied with monoclonal antibodies Blood 1982 59: 609–614

    CAS  PubMed  Google Scholar 

  3. Korsmeyer SJ, Greene WC, Cossman J, Hsu SM, Neckers L, Depper JM, Leonard WJ, Jaffe ES, Waldmann TA . Rearrangement and expression of immunoglobulin genes and expression of TAC antigen in hairy cell leukemia Proc Natl Acad Sci USA 1983 80: 4522–4526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Anderson KC, Boyd AW, Fischer DC, Leslie D, Schlossman SF, Nadler LM . Hairy cell leukemia: a tumor of pre-plasma cells Blood 1985 3: 620–629

    Google Scholar 

  5. Melo JV, San Miguel JF, Moss VE, Catovsky D . The membrane phenotype of hairy cell leukemia: a study with monoclonal antibodies Semin Oncol 1984 11: 381–385

    CAS  PubMed  Google Scholar 

  6. Troussard X, Maloisel F, Flandrin G . Hairy cell leukemia. What is new forty years after the first description? Hematol Cell Ther 1998 40: 139–148

    CAS  PubMed  Google Scholar 

  7. Juliusson G, Lenkei R, Liliemark J . Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine Blood 1994 83: 3672–3681

    CAS  PubMed  Google Scholar 

  8. Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D . The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders Blood 1994 83: 1558–1562

    CAS  PubMed  Google Scholar 

  9. Ford R, Yoshimura J, Morgan J, Quesada R, Montagna AD, Maizel AL . Growth factor mediated tumor cell proliferation in hairy cell leukemia J Exp Med 1985 162: 1093–1098

    Article  CAS  PubMed  Google Scholar 

  10. Génot E, Billard C, Sigaux F, Mathiot C, Degos L, Falcoff E, Kolb JP . Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon alpha and in vitro effects of interferon alpha, beta and gamma Leukemia 1987 1: 590–596

    PubMed  Google Scholar 

  11. Génot E, Sarfati M, Sigaux F, Petit-Koskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, Kolb JP . Effect of IFN-alpha on the expression and release of the CD23 molecule in hairy cell leukemia Blood 1989 7: 2455–2463

    Google Scholar 

  12. Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M . CD23 antigen regulation and signaling in chronic lymphocytic leukemia J Clin Invest 1992 89: 1312–1321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Barak V, Nisman B, Polliack A, Vannier E, Dinarello CA . Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia Eur Cytokine Netw 1998 9: 33–39

    CAS  PubMed  Google Scholar 

  14. Marcsek ZL, Konig EA . Accumulating mutations of p53 in colon tumor and hairy cell leukemia do not arise from methylation/deamination processes, but rather from nucleotide deletions and insertions Biol Chem 1998 379: 545–547

    CAS  PubMed  Google Scholar 

  15. de Boer CJ, Kluin-Nelemans JC, Dreef E, Kester MG, Kluin PM, Schuuring E, and van Krieken JH . Involvement of the CCND1 gene in hairy cell leukemia Ann Oncol 1996 7: 251–256

    Article  CAS  PubMed  Google Scholar 

  16. Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL . Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1 Blood 1996 88: 268–276

    CAS  PubMed  Google Scholar 

  17. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS . Nitric oxide produced by human lymphocytes inhibit apoptosis and Epstein–Barr virus reactivation Cell 1994 79: 1137–1146

    Article  CAS  PubMed  Google Scholar 

  18. Moncada S, Palmer RM, Higgs EA . Nitric oxide physiology, pathophysiology and pharmacology Pharmacol Rev 1991 43: 109–142

    CAS  PubMed  Google Scholar 

  19. Nathan C . Nitric oxide as a secretory product of mamalian cells FASEB J 1992 6: 3051–3064

    Article  CAS  PubMed  Google Scholar 

  20. Nathan CF, Xie QW . Nitric oxide synthases: roles, tolls, and controls Cell 1994 78: 915–918

    Article  CAS  PubMed  Google Scholar 

  21. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb JP . B-cell chronic lymphocytic leukemia express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 1998 92: 1031–1043

    CAS  PubMed  Google Scholar 

  22. Harvey W, Srour EF, Turner R, Carey R, Maze R, Starrett B, Kanagala R, Pereira D, Merchant P, Taylor M, Jansen J . Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogenic regulation and late B cell differentiation Leukemia Res 1991 15: 733–744

    Article  CAS  Google Scholar 

  23. Macdonald RJ, Swift GH, Przybyla AE, Chirgwin JM . Isolation of RNA using guanidinium salts Meth Enzymol 1987 152: 219–227

    Article  CAS  Google Scholar 

  24. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS . Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells Proc Natl Acad Sci USA 1994 91: 10089–10093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, and van Oers MHJ . Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 1994 84: 1415–1420

    CAS  PubMed  Google Scholar 

  26. Le Page C, Sanceau J, Drapier JC, Wietzerbin J . Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation Biochem Biophys Res Commun 1998 243: 451–457

    Article  CAS  PubMed  Google Scholar 

  27. Dimmeler S, Zeiher AM . Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide Nitric Oxide 1997 1: 275–281

    Article  CAS  PubMed  Google Scholar 

  28. Eigler A, Waller-Fontaine K, Moeller J, Hartmann G, Hacker UT, Endres S . The hairy cell leukemia cell line Eskol spontaneously synthesizes tumor necrosis factor-alpha and nitric oxide Leukemia Res 1998 22: 501–507

    Article  CAS  Google Scholar 

  29. Barak V, Nisman B, Polliack A . The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia Eur J Haematol 1999 62: 71–75

    Article  CAS  PubMed  Google Scholar 

  30. Dugas B, Mossalayi DM, Damais C, Kolb JP . Nitric oxide production by human monocytes/macrophages. Evidence for a role of CD23 Immunol Today 1995 16: 574–576

    Article  CAS  PubMed  Google Scholar 

  31. Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M . The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia Br J Haematol 1995 89: 373–379

    Article  CAS  PubMed  Google Scholar 

  32. Nicotera P, Brune B, Bagetta G . Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol Sci 1997 18: 189–190

    Article  CAS  PubMed  Google Scholar 

  33. Brune B, von Knethen A, Sandau KB . Nitric oxide and its role in apoptosis Eur J Pharmacol 1998 351: 261–272

    Article  CAS  PubMed  Google Scholar 

  34. Kim YM, Bombeck CA, Billiar TR . Nitric oxide as a bifunctional regulator of apoptosis Circ Res 1999 84: 253–256

    Article  CAS  PubMed  Google Scholar 

  35. Murphy MP . Nitric oxide and cell death Biochim Biophys Acta 1999 1411: 401–414

    Article  CAS  PubMed  Google Scholar 

  36. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L . Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels J Clin Invest 1995 95: 1884–1890

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hortelano S, Bosca L . 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes Mol Pharmacol 1997 51: 414–421

    CAS  PubMed  Google Scholar 

  38. Zaja F, Di Loreto C, Amoroso V, Salmaso F, Russo D, Silvestri F, Fanin R, Damiani D, Infanti L, Mariuzzi L, Beltrami CA, Baccarani M . BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine Leuk Lymphoma 1998 28: 567–572

    Article  CAS  PubMed  Google Scholar 

  39. Schlaifer D, Krajewski S, Galoin S, Rigal-Huguet F, Laurent G, Massip P, Pris J, Delsol G, Reed JC, Brousset P . Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection Am J Pathol 1996 149: 177–185

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Kim YM, Kim TH, Seol DW, Talanian RV, Billiar TR . Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release J Biol Chem 1998 273: 31437–31441

    Article  CAS  PubMed  Google Scholar 

  41. Haendeler J, Weiland U, Zeiher AM, Dimmeler S . Effects of redox-related congeners of NO on apoptosis and caspase-3 activity Nitric Oxide 1997 1: 282–293

    Article  CAS  PubMed  Google Scholar 

  42. Dimmeler S, Haendeler J, Nehls M, Zeiher AM . Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases J Exp Med 1997 185: 601–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mohr S, Zech B, Lapetina EG, Brune B . Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide Biochem Biophys Res Commun 1997 238: 387–391

    Article  CAS  PubMed  Google Scholar 

  44. Li J, Billiar TR, Talanian RV, Kim YM . Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation Biochem Biophys Res Commun 1997 240: 419–424

    Article  CAS  PubMed  Google Scholar 

  45. Kim YM, Talanian RV, Billiar TR . Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J Biol Chem 1997 272: 31138–33148

    Article  CAS  PubMed  Google Scholar 

  46. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, Dimmeler S . Nitric oxide inhibits caspase-3 by S-nitrosation in vivo J Biol Chem 1999 274: 6823–6826

    Article  CAS  PubMed  Google Scholar 

  47. Dimmeler S, Haendeler J, Sause A, Zeiher AM . Nitric oxide inhibits APO-1/Fas-mediated cell death Cell Growth Differ 1998 9: 415–422

    CAS  PubMed  Google Scholar 

  48. Mannick JB, Miao XQ, Stamler JS . Nitric oxide inhibits Fas-induced apoptosis J Biol Chem 1997 272: 24125–24128

    Article  CAS  PubMed  Google Scholar 

  49. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV . Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia Leukemia 1995 9: 1227–1232

    CAS  PubMed  Google Scholar 

  50. Tsuruda K, Yamada Y, Hirakata Y, Sugahara K, Maeda T, Atogami S, Tomonaga M, Kamihira S . Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms Leukemia Res 1999 23: 159–166

    Article  CAS  Google Scholar 

  51. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, Stamler JS . Fas-induced caspase denitrosylation Science 1999 284: 651–654

    Article  CAS  PubMed  Google Scholar 

  52. von Knethen A, Callsen D, Brune B . NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages Mol Biol Cell 1999 10: 361–372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kim YM, de Vera ME, Watkins SC, Billiar TR . Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression J Biol Chem 1997 272: 1402–1411

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by INSERM, Fondation contre la Leucémie and by a grant of ARC No. 9481. Viviana ROMAN is a recipient of a NATO fellowship from the Centre of Immunology, Institute Stefan Nicolaù, Bucharest (Roumania). The help of Danny Rouillard for FACS analysis was greatly appreciated. We also thank Jozo Delic for his help in fluorescence microscopy.

Author information

Authors and Affiliations

  1. INSERM U365, Institut Curie, Paris, France

    V Roman, H Zhao, J-M Fourneau, A Marconi & J-P Kolb

  2. Laboratoire Virus, Neurone et Immunité, IFR Kremlin Bicêtre, Bicêtre, France

    N Dugas

  3. Laboratoire Oxykine Therapeutics, Fractales Biotech, Jouy en Josas, Paris, France

    B Dugas

  4. INSERM U462, Hôpital Saint Louis, Paris, France

    F Sigaux

Authors
  1. V Roman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J-M Fourneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Marconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Dugas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Dugas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Sigaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J-P Kolb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roman, V., Zhao, H., Fourneau, JM. et al. Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line. Leukemia 14, 696–705 (2000). https://doi.org/10.1038/sj.leu.2401702

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401702

Keywords

This article is cited by

Search

Advanced search

Quick links